gabapentin-lactam has been researched along with Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, TJ; Gerds, TA; Landwehrmeyer, GB; Lücking, CH; Ludin, DE; Zucker, B | 1 |
1 other study(ies) available for gabapentin-lactam and Huntington Disease
| Article | Year |
|---|---|
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.
Topics: Amines; Animals; Anticonvulsants; Aza Compounds; Corpus Striatum; Cyclohexanecarboxylic Acids; Disease Models, Animal; Female; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Huntington Disease; Injections, Subcutaneous; Male; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Spiro Compounds; Survival Rate | 2004 |